Treatment Approach for MSI-H/dMMR CRC

 

UChicago Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics
M

Immunology & IO in Lynch Syndrome: Immune System, MSI & Hereditary Mismatch Deficiency, Current Therapies & Immuno-Prevention

By UChicago Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics FEATURING Michael J. Hall
By UChicago Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics FEATURING Michael J. Hall
110 views
February 16, 2021
0 Comments
Login to view comments. Click here to Login
Treatment Approach for MSI-H/dMMR CRC
05:20
ecancer

ASCO 2021 Update on Pembrolizumab vs. Chemo in MSI-H/dMMR mCRC: Fina…

Feat. T. André
30:44
LARVOL

ASCO 2021 Highlights on Advanced Gastrointestinal Cancers: 1L Nivo +…

Feat. M. Salem, M. Lewis, K. Knopf
27:09
2021 Virtual ESMO Review

ESMO 2021 Upper GI Updates: Advanced ESCC and GEJ, HER2+ GC, CAR T, …

Feat. S. Klempner
20:33
UChicago Medicine: Sixth Annual Updates in Digestive Diseases

Colon Cancer Screening and Surveillance in 2021

Feat. N. Sengupta
16:08
UChicago Medicine: Sixth Annual Updates in Digestive Diseases

Updates in Genetic Testing for Familial Cancers

Feat. C. Drogan
07:51
University of Colorado Cancer Center

Updates in dMMR/MSI CRC: Overview of Recent Immunotherapy Advances

Feat. W. Messersmith
18:08
10th Annual Winship Cancer Institute Gastrointestinal Cancer Virtual Symposium

Updates in Management of mCRC in Era of Comprehensive Genomic Analys…

Feat. C. Wu
44:02
Total Health

Expert Discussion on mCRC: Pembro vs. Chemo for MSI-H dMMR Disease, …

Feat. S. Jain, M. Cho, C. Eng, A. Loaiza-Bonilla, A. Parikh
09:44
ASCO GI 2022 Conference Coverage

ASCO GI 2022 Highlights: Clinical Utility of MSI-H Identified on Liq…

Feat. P. Kasi
14:06
ASCO GI 2022 Conference Coverage

ASCO GI 2022 on the Emerging Roles of ctDNA as a Tool in Metastatic …

Feat. A. Dasari
34:34
UChicago Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics

Immunology & IO in Lynch Syndrome: Immune System, MSI & Here…

Feat. M. J. Hall
20:38
Nilofer Saba Azad

Emerging Approaches for Immunotherapy in CRC

20:26
Collaborative Group of the Americas for Inherited Gastrointestinal Cancers

Incidental Findings From Somatic Testing and Implications for Heredi…

Feat. Z. Stadler
10:48
Daniel Ahn

Chemo & IO in MSI-H mCRC: What the Oncologist Should Know

24:51
UNC Lineberger Comprehensive Cancer Center

Updates in Treatment Sequencing by Molecular Profile in CRC and Bili…

Feat. H. K. Sanoff
13:15
Penn Medicine Abramson Cancer Center

Colorectal Liver Metastases: Liver-Directed Therapies - Embolization…

Feat. M. Soulen
15:26
Chiara Cremolini

Utilizing Single-Agent Immunotherapy in MSI-H CRC

19:03
2022 West Oncology Conference

Therapeutic Advances in CRC: The Real Deal or Just Hype?

Feat. V. Morris
11:02
Cleveland Clinic Taussig Cancer Institute

Prognostic and Predictive Value of Microsatellite Instability Status…

Feat. F. Baidoun
04:11
ASCO 2022 Conference Coverage

ASCO 2022 on CRC Metastatic dMMR Immuno-Therapy (COMMIT) Phase 3 Stu…

Feat. M. Overman
43
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on CRC Metastatic dMMR Immuno-Therapy (C…

Feat. M. Overman
08:41
ASCO 2022 Conference Coverage

ASCO 2022 on KEYNOTE-651: Pembrolizumab + mFOLFOX7/FOLFIRI for mCRC:…

Feat. R. Kim
01:02
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on Pembrolizumab + mFOLFOX7/FOLFIRI for …

Feat. R. Kim